IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,084 | -7.2% | 6,921 | -0.1% | 0.00% | – |
| Q2 2023 | $330,790 | -78.0% | 6,929 | -79.4% | 0.00% | – |
| Q1 2022 | $1,505,000 | -19.3% | 33,556 | -16.8% | 0.00% | – |
| Q4 2021 | $1,864,000 | +98.1% | 40,338 | -0.5% | 0.00% | – |
| Q2 2020 | $941,000 | +305.6% | 40,522 | +272.0% | 0.00% | – |
| Q1 2020 | $232,000 | -79.2% | 10,894 | -77.1% | 0.00% | – |
| Q4 2019 | $1,113,000 | +9.4% | 47,590 | -1.6% | 0.00% | – |
| Q3 2019 | $1,017,000 | +235.6% | 48,369 | +347.9% | 0.00% | – |
| Q1 2019 | $303,000 | -9.8% | 10,800 | -21.4% | 0.00% | – |
| Q4 2018 | $336,000 | -34.1% | 13,748 | +0.1% | 0.00% | – |
| Q3 2018 | $510,000 | -76.6% | 13,733 | -82.3% | 0.00% | -100.0% |
| Q4 2015 | $2,181,000 | +14.2% | 77,805 | -0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,910,000 | +31733.3% | 78,411 | +32707.9% | 0.00% | – |
| Q2 2015 | $6,000 | – | 239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |